vs
Side-by-side financial comparison of NATIONAL BANKSHARES INC (NKSH) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $15.3M, roughly 1.2× NATIONAL BANKSHARES INC). NATIONAL BANKSHARES INC runs the higher net margin — 38.5% vs -3.0%, a 41.5% gap on every dollar of revenue. On growth, NATIONAL BANKSHARES INC posted the faster year-over-year revenue change (24.7% vs -25.6%). NATIONAL BANKSHARES INC produced more free cash flow last quarter ($15.2M vs $2.2M). Over the past eight quarters, NATIONAL BANKSHARES INC's revenue compounded faster (20.9% CAGR vs -10.1%).
Nicolet Bankshares, Inc. is a U.S. regional bank holding company based in Green Bay, Wisconsin. They are the parent company of Nicolet National Bank, the second largest Wisconsin-based bank.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
NKSH vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.3M | $18.3M |
| Net Profit | $5.9M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 47.4% | -2.2% |
| Net Margin | 38.5% | -3.0% |
| Revenue YoY | 24.7% | -25.6% |
| Net Profit YoY | 91.0% | 26.7% |
| EPS (diluted) | $0.93 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $15.3M | $18.3M | ||
| Q3 25 | $14.2M | $15.9M | ||
| Q2 25 | $13.3M | $16.1M | ||
| Q1 25 | $12.8M | $18.9M | ||
| Q4 24 | $12.2M | $24.7M | ||
| Q3 24 | $11.7M | $28.3M | ||
| Q2 24 | $10.9M | $25.8M | ||
| Q1 24 | $10.4M | $22.7M |
| Q4 25 | $5.9M | $-554.0K | ||
| Q3 25 | $4.4M | $-1.8M | ||
| Q2 25 | $2.3M | $-1.5M | ||
| Q1 25 | $3.2M | $-1.5M | ||
| Q4 24 | $3.1M | $-756.0K | ||
| Q3 24 | $2.7M | $1.7M | ||
| Q2 24 | $-307.0K | $343.0K | ||
| Q1 24 | $2.2M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 47.4% | -2.2% | ||
| Q3 25 | 37.9% | -9.9% | ||
| Q2 25 | 20.0% | -8.4% | ||
| Q1 25 | 30.5% | -7.2% | ||
| Q4 24 | 30.1% | -2.1% | ||
| Q3 24 | 27.5% | 6.8% | ||
| Q2 24 | -4.4% | 2.0% | ||
| Q1 24 | 25.8% | -5.8% |
| Q4 25 | 38.5% | -3.0% | ||
| Q3 25 | 31.1% | -11.0% | ||
| Q2 25 | 17.2% | -9.3% | ||
| Q1 25 | 25.3% | -8.0% | ||
| Q4 24 | 25.1% | -3.1% | ||
| Q3 24 | 22.8% | 5.9% | ||
| Q2 24 | -2.8% | 1.3% | ||
| Q1 24 | 20.8% | -7.6% |
| Q4 25 | $0.93 | $-0.01 | ||
| Q3 25 | $0.69 | $-0.05 | ||
| Q2 25 | $0.36 | $-0.05 | ||
| Q1 25 | $0.51 | $-0.04 | ||
| Q4 24 | $0.50 | $-0.02 | ||
| Q3 24 | $0.42 | $0.04 | ||
| Q2 24 | $-0.05 | $0.01 | ||
| Q1 24 | $0.37 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $59.3M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $184.9M | $37.0M |
| Total Assets | $1.8B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $59.3M | $10.7M | ||
| Q3 25 | $42.3M | $13.6M | ||
| Q2 25 | $92.8M | $12.5M | ||
| Q1 25 | $122.5M | $11.4M | ||
| Q4 24 | $108.1M | $15.7M | ||
| Q3 24 | $49.8M | $12.3M | ||
| Q2 24 | $98.9M | $11.9M | ||
| Q1 24 | $121.2M | $6.6M |
| Q4 25 | $184.9M | $37.0M | ||
| Q3 25 | $179.2M | $37.0M | ||
| Q2 25 | $168.7M | $30.4M | ||
| Q1 25 | $167.3M | $31.5M | ||
| Q4 24 | $156.4M | $32.6M | ||
| Q3 24 | $167.8M | $29.1M | ||
| Q2 24 | $149.0M | $23.5M | ||
| Q1 24 | $139.4M | $20.6M |
| Q4 25 | $1.8B | $57.1M | ||
| Q3 25 | $1.8B | $57.5M | ||
| Q2 25 | $1.8B | $52.6M | ||
| Q1 25 | $1.8B | $54.0M | ||
| Q4 24 | $1.8B | $59.2M | ||
| Q3 24 | $1.8B | $57.1M | ||
| Q2 24 | $1.8B | $53.0M | ||
| Q1 24 | $1.7B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.9M | $2.3M |
| Free Cash FlowOCF − Capex | $15.2M | $2.2M |
| FCF MarginFCF / Revenue | 99.2% | 12.0% |
| Capex IntensityCapex / Revenue | 17.9% | 0.5% |
| Cash ConversionOCF / Net Profit | 3.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $23.6M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.9M | $2.3M | ||
| Q3 25 | $6.1M | $-1.3M | ||
| Q2 25 | $2.1M | $1.8M | ||
| Q1 25 | $2.6M | $-3.5M | ||
| Q4 24 | $9.4M | $865.0K | ||
| Q3 24 | $3.1M | $4.3M | ||
| Q2 24 | $-3.0M | $1.4M | ||
| Q1 24 | $3.8M | $-2.4M |
| Q4 25 | $15.2M | $2.2M | ||
| Q3 25 | $5.3M | $-1.5M | ||
| Q2 25 | $1.5M | $1.7M | ||
| Q1 25 | $1.6M | $-3.5M | ||
| Q4 24 | $6.2M | $470.0K | ||
| Q3 24 | $2.2M | $4.1M | ||
| Q2 24 | $-4.0M | $1.2M | ||
| Q1 24 | $3.5M | $-2.5M |
| Q4 25 | 99.2% | 12.0% | ||
| Q3 25 | 37.4% | -9.6% | ||
| Q2 25 | 11.5% | 10.5% | ||
| Q1 25 | 12.5% | -18.8% | ||
| Q4 24 | 50.5% | 1.9% | ||
| Q3 24 | 18.5% | 14.4% | ||
| Q2 24 | -36.3% | 4.5% | ||
| Q1 24 | 33.8% | -11.1% |
| Q4 25 | 17.9% | 0.5% | ||
| Q3 25 | 5.6% | 1.4% | ||
| Q2 25 | 4.1% | 1.0% | ||
| Q1 25 | 7.5% | 0.3% | ||
| Q4 24 | 26.6% | 1.6% | ||
| Q3 24 | 8.3% | 0.7% | ||
| Q2 24 | 9.3% | 1.1% | ||
| Q1 24 | 3.0% | 0.6% |
| Q4 25 | 3.04× | — | ||
| Q3 25 | 1.38× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 3.07× | — | ||
| Q3 24 | 1.17× | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | 1.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NKSH
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
